ClinicalTrials.gov
public full text
Public Domain
DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System
To confirm the safety and performance of the DynamX Sirolimus-eluting Coronary Bioadaptor System (SECBS) in de novo native coronary artery lesions using clinical and imaging endpoints. Clinical follow-up will be conducted in all patients at 30 days, 6 and 12 months. Imaging follow-up will be conducted at 6 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE#980409
- MIDCAB Versus DES in Proximal LAD Lesions#898255
- The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.#839021
- Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial#813811
- Long-term outcomes of hydrodynamic ultra-thin strut sirolimus-eluting stent with fluoropolymer containing triflusal: VELAZQUEZ-EPIC26 study#337248
Record · ID 825129
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive